Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Dose Response Curve: Conventional Versus Nonmonotonic

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

Dosage Regimen Designs: Nomograms and Tabulations

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

Dose Size and Dosing Frequency: Determination Methods

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Accounting for extra-binomial variability with differentially expressed genetic pathway data: a collaborative bioinformatic study.

Stat (International Statistical Institute)·2023

Same author

Adjusting statistical benchmark risk analysis to account for non-spatial autocorrelation, with application to natural hazard risk assessment.

Journal of applied statistics·2022

Same author

Benchmark dose risk analysis with mixed-factor quantal data in environmental risk assessment.

Environmetrics·2021

Same author

'Single-subject studies'-derived analyses unveil altered biomechanisms between very small cohorts: implications for rare diseases.

Bioinformatics (Oxford, England)·2021

Same author

From terrorism to flooding: How vulnerable is your city?

Significance (Oxford, England)·2021

Same author

Quantal Risk Assessment Database: A Database for Exploring Patterns in Quantal Dose-Response Data in Risk Assessment and its Application to Develop Priors for Bayesian Dose-Response Analysis.

Risk analysis : an official publication of the Society for Risk Analysis·2018

Search research articles

Related Experiment Video

Updated: May 9, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Benchmark dose profiles for joint-action continuous data in quantitative risk assessment.

Roland C Deutsch¹, Walter W Piegorsch

¹Department of Mathematics & Statistics, The University of North Carolina at Greensboro, 317 College Avenue, Greensboro, NC 27402, USA. roland.c.deutsch@gmail.com

Biometrical Journal. Biometrische Zeitschrift

|July 16, 2013

Summary

This summary is machine-generated.

This study expands benchmark dose (BMD) analysis for assessing risks from single agents to evaluating joint actions of two agents. It introduces a benchmark profile for characterizing combined exposure risks in toxicology and risk assessment.

Keywords:

Benchmark analysis Benchmark dose approach Benchmark profile Joint-action model Nonquantal data Risk analysis

More Related Videos

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System

Published on: January 12, 2024

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Related Experiment Videos

Last Updated: May 9, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System

Published on: January 12, 2024

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Area of Science:

Toxicology
Environmental Health
Biostatistics

Background:

Benchmark dose (BMD) analysis is crucial for biomedical and environmental risk assessment.
Estimating BMDs for a single agent and a specific response is well-established.
Current methods for assessing joint-action risks of multiple agents are less developed.

Purpose of the Study:

To extend the benchmark dose modeling paradigm to two-agent, joint-action studies.
To develop methods for quantitative risk characterization in combined exposure scenarios.
To focus on continuous response outcomes in risk assessment.

Main Methods:

Developed a joint-action dose-response model for two agents.
Extended the concept of benchmark dose to a two-dimensional benchmark profile.
Applied the model to continuous response outcomes.

Main Results:

Successfully expanded the benchmark approach to joint-action studies.
Defined a benchmark profile as a two-dimensional analog of the single-dose BMD.
Provided a framework for quantitative risk characterization of combined exposures.

Conclusions:

The benchmark modeling paradigm can be effectively extended to assess risks from two agents acting jointly.
The benchmark profile offers a novel tool for risk characterization in complex exposure scenarios.
This work advances the quantitative assessment of environmental and biomedical risks from combined exposures.